Shaohua Le
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term outcomes with emicizumab prophylaxis for haemophilia A in China: A multicentre, large-cohort retrospective study.
Journal: British journal of haematology
Published: January 20, 2026
KIT and FLT3-ITD mutations do not predict outcomes in pediatric core-binding factor acute myeloid leukemia: findings from the C-HUANAN-AML-15 multicenter cohort study.
Journal: Annals of hematology
Published: December 29, 2025
Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia.
Journal: Cancer medicine
Published: September 17, 2025
Clinical characteristics and outcome of pediatric patients with high-risk acute promyelocytic leukemia, with special focus on risk factors of early death.
Journal: Annals of hematology
Published: November 16, 2024
Experience in improving treatment outcomes for childhood acute lymphoblastic leukemia: real-world results for a province in China, 2011-2020.
Journal: Leukemia & lymphoma
Published: May 20, 2024
The correlation of asparaginase enzyme activity levels after PEG-asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: April 01, 2024
Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia.
Journal: BMC cancer
Published: May 09, 2023
High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia.
Journal: Frontiers in oncology
Published: May 21, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026